Author:
Sen Priyanka,Oberton Selby
Publisher
Springer International Publishing
Reference32 articles.
1. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116(5):497–505.
2. Lietz K. Destination therapy: patient selection and current outcomes. J Card Surg. 2010;25(4):462–71.
3. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4S):S1–39.
4. Puehler T, Ensminger S, Schoenbrodt M, et al. Mechanical circulatory support devices as destination therapy—current evidence. Ann Cardiothorac Surg. 2014;3(5):513–24.
5. Oz MC, Godstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 1995;92:II169–73.